The importance of L-carnitine in patients with chronic renal failure treated with hemodialysis;Význam L-karnitinu u pacientů s chronickým renálním selháním léčených hemodialýzou

Vnitrni Lekarstvi

Volumn 51, Issue 10, 2005, Pages 1108-1113

  Cibulka, Roman ^a   Racek, J ^a   Vesela E ^b  

^a CHARLES UNIVERSITY   (Czech Republic)

^b Hemodialyza ní St edisko EuroCare   (Czech Republic)

Author keywords

Chronic renal failure; Complications of dialysis treatment; Dysfunctions of metabolism; Hemodialysis; L carnitine

Indexed keywords

CARNITINE; LONG CHAIN FATTY ACID;

ANEMIA; ATHEROSCLEROSIS; CALCIUM METABOLISM; CARNITINE DEFICIENCY; CHRONIC KIDNEY FAILURE; ERYTHROCYTE COUNT; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; HEART MUSCLE; HEMODIALYSIS; HUMAN; HYPERPARATHYROIDISM; LIPID METABOLISM; MITOCHONDRIAL MEMBRANE; MUSCLE CELL; NUTRITION; OXIDATIVE STRESS; PHOSPHATE METABOLISM; REVIEW;

EID: 30744444676     PISSN: 0042773X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. Ahmad S, Robertson HT, Golper TA et al. Multicenter trial of L-carnitine in maintenance hemodialysis patients (II). Clinical and biochemical effects. Kidney Int 1990; 38: 912-918.
2. Battistella PA, Angelini C, Vergani L et al. Carnitine deficiency induced during hemodialysis. Lancet 1978; 1: 939.
3. Bellinghieri G, Santoro D, Calvani M et al. Carnitine and hemodialysis. Am J Kidney Dis 2003; 41: 116-122.
4. Bellinghieri G, Savica V, Mallamace A et al. Correlation between increased serum and tissue L-carnitine levels and improved muscle symptoms in hemodialyzed patients. Am J Clin Nutr 1983; 38: 523-531.
5. Bérard E, Barrillon D, Iordache A et al. Low dose of L-carnitine impairs membrane fragility of erythrocytes in hemodialysis patients. Nephron 1994; 68: 145.
6. Bérard E, Iordache A. Effect of low doses of L-carnitine on the response to recombinant human erythropoietin in hemodialysed children: about two cases. Nephron 1992; 62: 368-369.
7. Bohmer T, Bergrem H, Eiklid K. Carnitine deficiency induced during intermitent haemodialysis for renal failure. Lancet 1978; 1: 126-128.
8. Boran M, Dalva I, Gonenc F et al. Response to recombinant human erythropoietin (r-HuEPO) and L-carnitine combination in patients with anemia of end-stage renal disease. Nephron 1996; 73: 314-315.
9. Broulík P. Poruchy kalciofosfátového metabolismu. Praha: Grada Publishing 2003.
10. Ceriello A. New insights on oxidative stress and diabetic complications may lead to a "casual" antioxidant therapy. Diabetes Care 2003; 26: 1589-1596.
11. De Felice SL, Lyons P, Caffar MC et al. U.S.-Italy L-carnitine hemodialysis utilization survey. Dial Transplant 1996, 25: 368-373.
12. Eiselt J, Racek J, Opatrný K jr. Volné radikály a mimotělní náhrada funkce ledvin. Vnitř Lék 1999; 45: 319-324.
13. Eknoyan G, Latos DL, Lindberg J. Practice Recommendations for the Use of L-Carnitine in Dialysis-Related Carnitine Disorder. National Kidney Foundation Carnitine Consensus Conference. Amer J Kidney Dis 2003; 41: 868-876.
14. Eschbach JW, Adamson JW. Anemia of end-stage renal disease. Kidney Int 1985; 28: 1-5.
15. Evans AM, Faull R, Fornasini G et al. Pharmacokinetics of L-carnitine in patients with end-stage renal disease undergoing long-term hemodialysis. Clin Pharmacol Ther 2000; 68: 238-249.
16. Golper TA, Ahmad S. L-carnitine administration to hemodialysis patients: Has its time come? Semin Dial 1992; 5: 94-98.
17. Golper TA, Goral S, Becker BN et al. L-carnitine treatment of anemia. Am J Kidney Dis 2003; 41(Suppl 4): S27-S34.
18. Goral S. Levocarnitine's Role in the Treatment of Patients with End-Stage Renal Disease: A Review. Dial Transplant 2001; 30: 530-538.
19. Gunal AI, Celiker H, Donder E et al. The effect of L-carnitine on insulin resistance in hemodialysed patients with chronic renal failure. J Nephrol 1999; 12: 38-40.
20. Hagen TM, Liu J, Lykkesfeldt J et al. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci USA 2002; 99: 1870-1875.
21. Kumaran S, Deepak B, Naveen B et al. Effects of levocarnitine on mitochondrial antioxidant systems and oxidative stress in aged rats. Drugs R D 2003; 4: 141-147.
22. Labonia WD, Morelli OH jr, Gimenez MI et al. Effects of L-carnitine on sodium transport in erytrocytes from dialyzed uremic patients. Kidney Int 1987; 32: 754-759.
23. Maeda K, Shinzato T, Kobayakawa H. Effects of L-carnitine administration on schort chain fatty acids (acetic acid) and long-chain fatty acid metabolism during hemodialysis. Nephron 1989; 51: 355-361.
24. National Kidney Foundation: K/DOQI Clinical Practice Guidelines for Nutrition in Chronic Renal Failure. Am J Kidney Dis 2000; 35(Suppl 2): S1-S140.
25. Racek J et al. Klinická biochemie. Praha: Galén 1999.
26. Rasic-Milutinovic Z, Perunicic-Peckovic G, Pljesa S. Clinical significance and pathogenic mechanisms of insulin resistance in chronic renal insufficiency (part II): pathogenic factors of insulin resistance in chronic renal insufficiency. Med Pregl 2000; 53: 159-163.
27. Sener G, Paskaloglu K, Satiroglu H et al. L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol 2004; 43: 698-705.
28. Shug AL, Subramanian R. Modulation of adenine nucleotide translocase activity during myocardial ischemia. Z Kardiol 1987; 75: 26-33.
29. Schück O. Proteinová dieta a funkce ledvin. Lékařské listy 2004; 40: 20-21.
30. Schück O, Tesař V, Teplan V et al. Klinická nefrologie. Praha: Medprint 1995.
31. Slatopolsky E, Finch J, Denda M et al. Phosphrus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 1996; 96: 2534-2540.
32. Steidl L, Zbránková B. Význam karnitinu a jeho použití v medicíně. Praha: Triton 2000: 28-29.
33. Steidl L, Zbránková B. Význam karnitinu a jeho použití v medicíně. Praha: Triton 2000: 72-77.
34. Vazelov E, Borissova AM, Kirilov G et al. L-carnitine consecutively administered to patients on hemodialysis improves beta-cell response. Int J Artif Organs 2003; 26: 304-307.
35. Veselá E, Racek J, Trefil L et al. Effect of L-carnitine supplementation in hemodialysis patients. Nephron 2001; 88: 218-223.